Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

about

Hepatitis B infection reported with cancer chemotherapy: analyzing the US FDA Adverse Event Reporting System.Pharmacovigilance in oncology

P2860

Q54234367-CC99A164-05D6-4446-9B87-DA3484276D44 Q58804356-54C13091-E6A7-43C8-8D91-5F78ED49B1D2

P2860

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

Item

http://www.wikidata.org/entity/Q41784210

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

@en

type

Item

label

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

@en

prefLabel

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

@en

P1476

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

@en

P2093

Ankur Arora

http://www.w3.org/2001/XMLSchema#string

Rajinder K Jalali

http://www.w3.org/2001/XMLSchema#string

P2860

Bias in spontaneous reporting of adverse drug reactions in Japan

Novel data-mining methodologies for adverse drug event discovery and analysis

Data mining of the public version of the FDA Adverse Event Reporting System

Adverse event reporting patterns of newly approved drugs in the USA in 2006: an analysis of FDA Adverse Event Reporting System data.

Exploring the FDA adverse event reporting system to generate hypotheses for monitoring of disease characteristics.

Dabigatran and postmarketing reports of bleeding.

Use of dipeptidyl peptidase-4 inhibitors and the reporting of infections: a disproportionality analysis in the World Health Organization VigiBase.

The role of the Internet in patient-practitioner relationships: findings from a qualitative research study

Limitations and obstacles of the spontaneous adverse drugs reactions reporting: Two "challenging" case reports.

Pharmacovigilance in oncology: evaluation of current practice and future perspectives.

P304

1195-1203

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/TCRM.S137144

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Divya Vohora

P577

2017-09-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28979130

http://www.w3.org/2001/XMLSchema#string

P932

5602442

http://www.w3.org/2001/XMLSchema#string

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

about

P2860

P2860

Relevance of the Weber effect in contemporary pharmacovigilance of oncology drugs.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932